ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GLP-1 for Weight Loss Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-27H12759
Home | Market Reports | Beauty & Fitness| Weight Loss
Global GLP 1 for Weight Loss Market Research Report 2023
BUY CHAPTERS

Global GLP-1 for Weight Loss Market Research Report 2025

Code: QYRE-Auto-27H12759
Report
May 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lily
GSK
Sanofi
Bristol–Myers Squibb
Amylin
Astrazeneca plc
Novo Nordisk

GLP-1 for Weight Loss Market Size

The global market for GLP-1 for Weight Loss was valued at US$ 4067 million in the year 2024 and is projected to reach a revised size of US$ 14750 million by 2031, growing at a CAGR of 20.5% during the forecast period.

GLP-1 for Weight Loss Market

GLP-1 for Weight Loss Market

GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone in the body that plays a role in glucose homeostasis and appetite regulation. In the context of weight loss, GLP-1 has gained attention due to its potential to influence body weight.
GLP-1-based medications, such as GLP-1 receptor agonists, are a class of drugs used primarily for the treatment of type 2 diabetes. However, they have also been found to have beneficial effects on body weight. These drugs mimic the action of GLP-1 in the body, leading to increased insulin secretion, decreased glucagon release, slowed gastric emptying, and a sense of fullness. These effects collectively contribute to improved blood sugar control and a reduction in appetite and food intake.
Expanding Indications: GLP-1 receptor agonists were primarily developed for the treatment of type 2 diabetes. However, there was growing interest in their potential application for weight management in individuals without diabetes. Some GLP-1 medications received regulatory approval for weight loss.
New Drug Development: Pharmaceutical companies were investing in the research and development of new GLP-1 receptor agonists with enhanced properties, including improved efficacy, longer duration of action, and better tolerability. These developments aimed to address various patient needs and preferences.
Combination Therapies: Researchers were exploring the use of GLP-1 medications in combination with other weight loss therapies, such as anti-obesity medications or lifestyle interventions. Combining different approaches could provide synergistic effects in promoting weight loss.
Increased Patient Awareness: As more research findings became available and regulatory approvals were granted for weight management, there was an increased awareness among healthcare professionals and patients regarding the potential benefits of GLP-1 receptor agonists for weight loss.
Market Competition: With the emergence of new medications and indications, the market for GLP-1-based therapies for weight loss was becoming more competitive. This competition could drive innovation and potentially lead to more accessible and diverse treatment options.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GLP-1 for Weight Loss, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 for Weight Loss.
The GLP-1 for Weight Loss market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GLP-1 for Weight Loss market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP-1 for Weight Loss manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of GLP-1 for Weight Loss Market Report

Report Metric Details
Report Name GLP-1 for Weight Loss Market
Accounted market size in year US$ 4067 million
Forecasted market size in 2031 US$ 14750 million
CAGR 20.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Woman
  • Man
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Bristol-Myers Squibb, Amylin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of GLP-1 for Weight Loss manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of GLP-1 for Weight Loss in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is GLP-1 for Weight Loss Market growing?

Ans: The GLP-1 for Weight Loss Market witnessing a CAGR of 20.5% during the forecast period 2025-2031.

What is the GLP-1 for Weight Loss Market size in 2031?

Ans: The GLP-1 for Weight Loss Market size in 2031 will be US$ 14750 million.

Who are the main players in the GLP-1 for Weight Loss Market report?

Ans: The main players in the GLP-1 for Weight Loss Market are Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Bristol-Myers Squibb, Amylin

What are the Application segmentation covered in the GLP-1 for Weight Loss Market report?

Ans: The Applications covered in the GLP-1 for Weight Loss Market report are Woman, Man

What are the Type segmentation covered in the GLP-1 for Weight Loss Market report?

Ans: The Types covered in the GLP-1 for Weight Loss Market report are Injection, Oral Agent

Recommended Reports

GLP-1 Medications

Weight Loss Medicines

GLP-1 Market Segments

1 GLP-1 for Weight Loss Market Overview
1.1 Product Definition
1.2 GLP-1 for Weight Loss by Type
1.2.1 Global GLP-1 for Weight Loss Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection
1.2.3 Oral Agent
1.3 GLP-1 for Weight Loss by Application
1.3.1 Global GLP-1 for Weight Loss Market Value by Application (2024 VS 2031)
1.3.2 Woman
1.3.3 Man
1.4 Global GLP-1 for Weight Loss Market Size Estimates and Forecasts
1.4.1 Global GLP-1 for Weight Loss Revenue 2020-2031
1.4.2 Global GLP-1 for Weight Loss Sales 2020-2031
1.4.3 Global GLP-1 for Weight Loss Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 GLP-1 for Weight Loss Market Competition by Manufacturers
2.1 Global GLP-1 for Weight Loss Sales Market Share by Manufacturers (2020-2025)
2.2 Global GLP-1 for Weight Loss Revenue Market Share by Manufacturers (2020-2025)
2.3 Global GLP-1 for Weight Loss Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of GLP-1 for Weight Loss, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GLP-1 for Weight Loss, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP-1 for Weight Loss, Product Type & Application
2.7 Global Key Manufacturers of GLP-1 for Weight Loss, Date of Enter into This Industry
2.8 Global GLP-1 for Weight Loss Market Competitive Situation and Trends
2.8.1 Global GLP-1 for Weight Loss Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GLP-1 for Weight Loss Players Market Share by Revenue
2.8.3 Global GLP-1 for Weight Loss Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 for Weight Loss Market Scenario by Region
3.1 Global GLP-1 for Weight Loss Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global GLP-1 for Weight Loss Sales by Region: 2020-2031
3.2.1 Global GLP-1 for Weight Loss Sales by Region: 2020-2025
3.2.2 Global GLP-1 for Weight Loss Sales by Region: 2026-2031
3.3 Global GLP-1 for Weight Loss Revenue by Region: 2020-2031
3.3.1 Global GLP-1 for Weight Loss Revenue by Region: 2020-2025
3.3.2 Global GLP-1 for Weight Loss Revenue by Region: 2026-2031
3.4 North America GLP-1 for Weight Loss Market Facts & Figures by Country
3.4.1 North America GLP-1 for Weight Loss Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America GLP-1 for Weight Loss Sales by Country (2020-2031)
3.4.3 North America GLP-1 for Weight Loss Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 for Weight Loss Market Facts & Figures by Country
3.5.1 Europe GLP-1 for Weight Loss Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe GLP-1 for Weight Loss Sales by Country (2020-2031)
3.5.3 Europe GLP-1 for Weight Loss Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 for Weight Loss Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 for Weight Loss Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific GLP-1 for Weight Loss Sales by Region (2020-2031)
3.6.3 Asia Pacific GLP-1 for Weight Loss Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 for Weight Loss Market Facts & Figures by Country
3.7.1 Latin America GLP-1 for Weight Loss Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America GLP-1 for Weight Loss Sales by Country (2020-2031)
3.7.3 Latin America GLP-1 for Weight Loss Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 for Weight Loss Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 for Weight Loss Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa GLP-1 for Weight Loss Sales by Country (2020-2031)
3.8.3 Middle East and Africa GLP-1 for Weight Loss Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 for Weight Loss Sales by Type (2020-2031)
4.1.1 Global GLP-1 for Weight Loss Sales by Type (2020-2025)
4.1.2 Global GLP-1 for Weight Loss Sales by Type (2026-2031)
4.1.3 Global GLP-1 for Weight Loss Sales Market Share by Type (2020-2031)
4.2 Global GLP-1 for Weight Loss Revenue by Type (2020-2031)
4.2.1 Global GLP-1 for Weight Loss Revenue by Type (2020-2025)
4.2.2 Global GLP-1 for Weight Loss Revenue by Type (2026-2031)
4.2.3 Global GLP-1 for Weight Loss Revenue Market Share by Type (2020-2031)
4.3 Global GLP-1 for Weight Loss Price by Type (2020-2031)
5 Segment by Application
5.1 Global GLP-1 for Weight Loss Sales by Application (2020-2031)
5.1.1 Global GLP-1 for Weight Loss Sales by Application (2020-2025)
5.1.2 Global GLP-1 for Weight Loss Sales by Application (2026-2031)
5.1.3 Global GLP-1 for Weight Loss Sales Market Share by Application (2020-2031)
5.2 Global GLP-1 for Weight Loss Revenue by Application (2020-2031)
5.2.1 Global GLP-1 for Weight Loss Revenue by Application (2020-2025)
5.2.2 Global GLP-1 for Weight Loss Revenue by Application (2026-2031)
5.2.3 Global GLP-1 for Weight Loss Revenue Market Share by Application (2020-2031)
5.3 Global GLP-1 for Weight Loss Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk GLP-1 for Weight Loss Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca GLP-1 for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca GLP-1 for Weight Loss Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Eli Lily
6.3.1 Eli Lily Company Information
6.3.2 Eli Lily Description and Business Overview
6.3.3 Eli Lily GLP-1 for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lily GLP-1 for Weight Loss Product Portfolio
6.3.5 Eli Lily Recent Developments/Updates
6.4 GSK
6.4.1 GSK Company Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK GLP-1 for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GSK GLP-1 for Weight Loss Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi GLP-1 for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi GLP-1 for Weight Loss Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Company Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb GLP-1 for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bristol-Myers Squibb GLP-1 for Weight Loss Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
6.7 Amylin
6.7.1 Amylin Company Information
6.7.2 Amylin Description and Business Overview
6.7.3 Amylin GLP-1 for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Amylin GLP-1 for Weight Loss Product Portfolio
6.7.5 Amylin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 for Weight Loss Industry Chain Analysis
7.2 GLP-1 for Weight Loss Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 for Weight Loss Production Mode & Process Analysis
7.4 GLP-1 for Weight Loss Sales and Marketing
7.4.1 GLP-1 for Weight Loss Sales Channels
7.4.2 GLP-1 for Weight Loss Distributors
7.5 GLP-1 for Weight Loss Customer Analysis
8 GLP-1 for Weight Loss Market Dynamics
8.1 GLP-1 for Weight Loss Industry Trends
8.2 GLP-1 for Weight Loss Market Drivers
8.3 GLP-1 for Weight Loss Market Challenges
8.4 GLP-1 for Weight Loss Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Eli Lily
GSK
Sanofi
Bristol–Myers Squibb
Amylin
Astrazeneca plc
Novo Nordisk
List of Tables
 Table 1. Global GLP-1 for Weight Loss Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global GLP-1 for Weight Loss Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global GLP-1 for Weight Loss Market Competitive Situation by Manufacturers in 2024
 Table 4. Global GLP-1 for Weight Loss Sales (Kg) of Key Manufacturers (2020-2025)
 Table 5. Global GLP-1 for Weight Loss Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global GLP-1 for Weight Loss Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global GLP-1 for Weight Loss Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market GLP-1 for Weight Loss Average Price (US$/Mg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of GLP-1 for Weight Loss, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of GLP-1 for Weight Loss, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of GLP-1 for Weight Loss, Product Type & Application
 Table 12. Global Key Manufacturers of GLP-1 for Weight Loss, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GLP-1 for Weight Loss by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 for Weight Loss as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GLP-1 for Weight Loss Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global GLP-1 for Weight Loss Sales by Region (2020-2025) & (Kg)
 Table 18. Global GLP-1 for Weight Loss Sales Market Share by Region (2020-2025)
 Table 19. Global GLP-1 for Weight Loss Sales by Region (2026-2031) & (Kg)
 Table 20. Global GLP-1 for Weight Loss Sales Market Share by Region (2026-2031)
 Table 21. Global GLP-1 for Weight Loss Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global GLP-1 for Weight Loss Revenue Market Share by Region (2020-2025)
 Table 23. Global GLP-1 for Weight Loss Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global GLP-1 for Weight Loss Revenue Market Share by Region (2026-2031)
 Table 25. North America GLP-1 for Weight Loss Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America GLP-1 for Weight Loss Sales by Country (2020-2025) & (Kg)
 Table 27. North America GLP-1 for Weight Loss Sales by Country (2026-2031) & (Kg)
 Table 28. North America GLP-1 for Weight Loss Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America GLP-1 for Weight Loss Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe GLP-1 for Weight Loss Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe GLP-1 for Weight Loss Sales by Country (2020-2025) & (Kg)
 Table 32. Europe GLP-1 for Weight Loss Sales by Country (2026-2031) & (Kg)
 Table 33. Europe GLP-1 for Weight Loss Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe GLP-1 for Weight Loss Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific GLP-1 for Weight Loss Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific GLP-1 for Weight Loss Sales by Region (2020-2025) & (Kg)
 Table 37. Asia Pacific GLP-1 for Weight Loss Sales by Region (2026-2031) & (Kg)
 Table 38. Asia Pacific GLP-1 for Weight Loss Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific GLP-1 for Weight Loss Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America GLP-1 for Weight Loss Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America GLP-1 for Weight Loss Sales by Country (2020-2025) & (Kg)
 Table 42. Latin America GLP-1 for Weight Loss Sales by Country (2026-2031) & (Kg)
 Table 43. Latin America GLP-1 for Weight Loss Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America GLP-1 for Weight Loss Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa GLP-1 for Weight Loss Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa GLP-1 for Weight Loss Sales by Country (2020-2025) & (Kg)
 Table 47. Middle East and Africa GLP-1 for Weight Loss Sales by Country (2026-2031) & (Kg)
 Table 48. Middle East and Africa GLP-1 for Weight Loss Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa GLP-1 for Weight Loss Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global GLP-1 for Weight Loss Sales (Kg) by Type (2020-2025)
 Table 51. Global GLP-1 for Weight Loss Sales (Kg) by Type (2026-2031)
 Table 52. Global GLP-1 for Weight Loss Sales Market Share by Type (2020-2025)
 Table 53. Global GLP-1 for Weight Loss Sales Market Share by Type (2026-2031)
 Table 54. Global GLP-1 for Weight Loss Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global GLP-1 for Weight Loss Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global GLP-1 for Weight Loss Revenue Market Share by Type (2020-2025)
 Table 57. Global GLP-1 for Weight Loss Revenue Market Share by Type (2026-2031)
 Table 58. Global GLP-1 for Weight Loss Price (US$/Mg) by Type (2020-2025)
 Table 59. Global GLP-1 for Weight Loss Price (US$/Mg) by Type (2026-2031)
 Table 60. Global GLP-1 for Weight Loss Sales (Kg) by Application (2020-2025)
 Table 61. Global GLP-1 for Weight Loss Sales (Kg) by Application (2026-2031)
 Table 62. Global GLP-1 for Weight Loss Sales Market Share by Application (2020-2025)
 Table 63. Global GLP-1 for Weight Loss Sales Market Share by Application (2026-2031)
 Table 64. Global GLP-1 for Weight Loss Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global GLP-1 for Weight Loss Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global GLP-1 for Weight Loss Revenue Market Share by Application (2020-2025)
 Table 67. Global GLP-1 for Weight Loss Revenue Market Share by Application (2026-2031)
 Table 68. Global GLP-1 for Weight Loss Price (US$/Mg) by Application (2020-2025)
 Table 69. Global GLP-1 for Weight Loss Price (US$/Mg) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk GLP-1 for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk GLP-1 for Weight Loss Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca GLP-1 for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 78. AstraZeneca GLP-1 for Weight Loss Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Eli Lily Company Information
 Table 81. Eli Lily Description and Business Overview
 Table 82. Eli Lily GLP-1 for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 83. Eli Lily GLP-1 for Weight Loss Product
 Table 84. Eli Lily Recent Developments/Updates
 Table 85. GSK Company Information
 Table 86. GSK Description and Business Overview
 Table 87. GSK GLP-1 for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 88. GSK GLP-1 for Weight Loss Product
 Table 89. GSK Recent Developments/Updates
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi GLP-1 for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 93. Sanofi GLP-1 for Weight Loss Product
 Table 94. Sanofi Recent Developments/Updates
 Table 95. Bristol-Myers Squibb Company Information
 Table 96. Bristol-Myers Squibb Description and Business Overview
 Table 97. Bristol-Myers Squibb GLP-1 for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 98. Bristol-Myers Squibb GLP-1 for Weight Loss Product
 Table 99. Bristol-Myers Squibb Recent Developments/Updates
 Table 100. Amylin Company Information
 Table 101. Amylin Description and Business Overview
 Table 102. Amylin GLP-1 for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 103. Amylin GLP-1 for Weight Loss Product
 Table 104. Amylin Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. GLP-1 for Weight Loss Distributors List
 Table 108. GLP-1 for Weight Loss Customers List
 Table 109. GLP-1 for Weight Loss Market Trends
 Table 110. GLP-1 for Weight Loss Market Drivers
 Table 111. GLP-1 for Weight Loss Market Challenges
 Table 112. GLP-1 for Weight Loss Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GLP-1 for Weight Loss
 Figure 2. Global GLP-1 for Weight Loss Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global GLP-1 for Weight Loss Market Share by Type: 2024 & 2031
 Figure 4. Injection Product Picture
 Figure 5. Oral Agent Product Picture
 Figure 6. Global GLP-1 for Weight Loss Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global GLP-1 for Weight Loss Market Share by Application: 2024 & 2031
 Figure 8. Woman
 Figure 9. Man
 Figure 10. Global GLP-1 for Weight Loss Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global GLP-1 for Weight Loss Market Size (2020-2031) & (US$ Million)
 Figure 12. Global GLP-1 for Weight Loss Sales (2020-2031) & (Kg)
 Figure 13. Global GLP-1 for Weight Loss Average Price (US$/Mg) & (2020-2031)
 Figure 14. GLP-1 for Weight Loss Report Years Considered
 Figure 15. GLP-1 for Weight Loss Sales Share by Manufacturers in 2024
 Figure 16. Global GLP-1 for Weight Loss Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest GLP-1 for Weight Loss Players: Market Share by Revenue in GLP-1 for Weight Loss in 2024
 Figure 18. GLP-1 for Weight Loss Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global GLP-1 for Weight Loss Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America GLP-1 for Weight Loss Sales Market Share by Country (2020-2031)
 Figure 21. North America GLP-1 for Weight Loss Revenue Market Share by Country (2020-2031)
 Figure 22. United States GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe GLP-1 for Weight Loss Sales Market Share by Country (2020-2031)
 Figure 25. Europe GLP-1 for Weight Loss Revenue Market Share by Country (2020-2031)
 Figure 26. Germany GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific GLP-1 for Weight Loss Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific GLP-1 for Weight Loss Revenue Market Share by Region (2020-2031)
 Figure 33. China GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America GLP-1 for Weight Loss Sales Market Share by Country (2020-2031)
 Figure 41. Latin America GLP-1 for Weight Loss Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Colombia GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa GLP-1 for Weight Loss Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa GLP-1 for Weight Loss Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE GLP-1 for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of GLP-1 for Weight Loss by Type (2020-2031)
 Figure 52. Global Revenue Market Share of GLP-1 for Weight Loss by Type (2020-2031)
 Figure 53. Global GLP-1 for Weight Loss Price (US$/Mg) by Type (2020-2031)
 Figure 54. Global Sales Market Share of GLP-1 for Weight Loss by Application (2020-2031)
 Figure 55. Global Revenue Market Share of GLP-1 for Weight Loss by Application (2020-2031)
 Figure 56. Global GLP-1 for Weight Loss Price (US$/Mg) by Application (2020-2031)
 Figure 57. GLP-1 for Weight Loss Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global GLP 1 Weight Loss Drug Market Research Report 2024
Global GLP 1 Weight Loss Pill Market Research Report 2024
Global GLP 1 Receptor Agonist Drugs Market Research Report 2024
Global GLP 1 Agonists for Obesity Market Research Report 2024
Global GLP 1 based Therapy Market Research Report 2024
Global GLP 1 Agonists for the Treatment of both Diabetes and Obesity Market Research Report 2024
GLP Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Glucagon like peptide 1 GLP 1 based Therapies Market Research Report 2025
Global GLP 1 Drugs Market Research Report 2024
Global Glucagon Like Peptide 1 GLP 1 Agonists Market Research Report 2025
Global GLP 1 Receptor Antagonist Market Research Report 2024
Global GLP 1 Weight Loss Injection Market Research Report 2024
GLP 1 Analogues Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral GLP 1 Agonist Market Research Report 2024
Global GLP 1 Peptide Drugs Market Research Report 2024
Global Antidiabetic Glucagon like Peptide 1 Agonists Market Research Report 2025
Global GLP 1RA based Therapy for Obesity Market Research Report 2024
Global GLP 1 Agonist Injection Market Research Report 2024
GLP 1 for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1RA Therapy Market Research Report 2024

RELATED REPORTS

Global Appetite Suppressants Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0P3416
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Weight Loss Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9J8726
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Ankle Weight Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14J6832
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Weight Loss Programs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13T1916
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions